Search

everythinglearnresearchcommunity

for

Search:↓

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

Antibiotics often cause skin reactions, making them a major health concern.

Vasodilators may worsen abdominal aortic aneurysm.

RADA16-I can effectively deliver and release mangiferin, improving its solubility and bioavailability.

Certain amino acids in 5AR1 and 5AR2 are crucial for binding and resistance to Finasteride.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

Natural 5AR inhibitors effectively improve mild to moderate hair loss in men.

Asiasari Radix et Rhizoma is safe and has potential for new drug development due to its therapeutic properties.

5α-Reductase helps regulate hormone action in toad testes, especially during breeding season.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

5 alpha reductase inhibitors can cause sexual, cognitive, and muscle side effects, and may slightly increase aggressive cancer risk.

OR2AT4 helps reduce aging and cell damage in human skin cells.

Skin RAGE levels are linked to inflammation and cell death.

Ruxolitinib helped a patient with alopecia areata regrow hair.

5-alpha-reductase inhibitors help treat urinary symptoms from an enlarged prostate.

Redenyl lotion effectively promotes hair growth and improves quality of life for androgenetic alopecia patients.

ATR04-484 ointment shows promise for treating skin issues from cancer therapies.

A woman got a skin rash from taking aceclofenac, which went away after she stopped the drug.

5-alpha reductase inhibitors slightly reduce urinary symptoms and may lower surgery and acute retention risks in men.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

Upadacitinib effectively treats severe alopecia areata and is safe.

A new treatment for hair loss shows promise with fewer side effects.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Upadacitinib improved multiple immune-related conditions in one patient.

5-alpha-reductase inhibitors lower PSA density but higher PSA density indicates disease progression.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

Arteannuin might work against cancer and Alzheimer's by targeting neprilysin.